| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 673186 | Null | 0.0422011701988039 | 0.47291337 |
| NSC 673420 | Null | 0.0422011701988039 | 0.076349838 |
| NSC 675000 | Null | 0.0422011701988039 | 0.30228863 |
| NSC 676914 | 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid | 0.0422011701988039 | 0.19240963 |
| NSC 677275 | Null | 0.0422011701988039 | 0.033394865 |
| NSC 677672 | Null | 0.0422011701988039 | 0.13974823 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.0422011701988039 | 0.18765375 |
| NSC 681239 | Bortezomib | 0.0422011701988039 | 0.43584765 |
| NSC 681645 | Camptothecin Derivative | 0.0422011701988039 | 0.32671552 |
| NSC 682011 | Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- | 0.0422011701988039 | 0.21355375 |